Key Insights

Highlights

Success Rate

94% trial completion (above average)

Published Results

11 trials with published results (7%)

Research Maturity

94 completed trials (56% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

3.6%

6 terminated out of 167 trials

Success Rate

94.0%

+7.5% vs benchmark

Late-Stage Pipeline

7%

12 trials in Phase 3/4

Results Transparency

12%

11 of 94 completed with results

Key Signals

11 with results94% success

Data Visualizations

Phase Distribution

94Total
Not Applicable (34)
Early P 1 (6)
P 1 (17)
P 2 (25)
P 3 (9)
P 4 (3)

Trial Status

Completed94
Unknown30
Recruiting12
Active Not Recruiting9
Withdrawn8
Not Yet Recruiting7

Trial Success Rate

94.0%

Benchmark: 86.5%

Based on 94 completed trials

Clinical Trials (167)

Showing 20 of 20 trials
NCT07703475Phase 1Not Yet RecruitingPrimary

A Safety, Reactogenicity and Immunogenicity Trial of RVX-sCPD9 Booster Intranasal COVID-19 Vaccine

NCT07739446Not ApplicableEnrolling By Invitation

Randomized Controlled Trial to Evaluate the Efficacy of Surgical Masks in Preventing Acute Respiratory Infections

NCT07728396Phase 1Active Not RecruitingPrimary

A Phase 1 Study to Evaluate the Safety and Immunogenicity of GC4006A in Healthy Adults

NCT07416539Phase 1Active Not RecruitingPrimary

Effect of COV2 Vaccine Formulation on the Ability to Generate Antibodies Against Coronavirus That Causes COVID-19

NCT07711444Not ApplicableCompletedPrimary

The Efficacy of Long-Chain Fatty Acids, Eicosapentaenoic Acid (EPA) and Specialized Pro-Resolving Mediators (SPMs), in Treating Long COVID Neuropsychiatric Symptoms

NCT06698549Phase 1CompletedPrimary

A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of ALG-097558 in Subjects With Renal Impairment and in Healthy Subjects With Normal Renal Function

NCT06907251Phase 3Not Yet RecruitingPrimary

Dapagliflozin for Long COVID Syndrome

NCT04354558Active Not Recruiting

French Single Centre Experience of Critically Ill Patients With Covid 19

NCT07599449Not Yet Recruiting

Virological Surveillance of Acute Respiratory Infection in Primary Health Care in Metropolitan France

NCT06821139Completed

Cohort Study of Intraoperative Lung Protective Ventilation Trends in a Large Canadian Health Authority

NCT06761612CompletedPrimary

Retail COVID-19 Study

NCT07597889Not ApplicableCompletedPrimary

Diagnostic Accuracy of 2 cm Versus 4 cm Insertion Depth for Nasal Swabs for SARS-CoV-2 (COVID-19) Rapid Antigen Testing-A Randomized Controlled Trial

NCT07445971Phase 1RecruitingPrimary

A Study Evaluating MDX2301 in Healthy Adults and Adults at Higher Risk for Severe COVID-19.

NCT07302295Not ApplicableRecruiting

Analysis of Suicidal Behavior Among Children and Adolescents in the Auvergne-Rhone-Alpes Region During the Covid 19 Pandemic Period

NCT07569523Not Yet Recruiting

Development of Preterm Infants Born During the COVID-19 Pandemic

NCT07046442CompletedPrimary

Effect of Pulmonary Rehabilitation and Physical Activity on COVID-19 Long-Term Symptoms (PuReCOVID)

NCT07287137Phase 4Active Not Recruiting

Comparative Immunogenicity of Respiratory Virus Vaccines (CIRV2) Study

NCT06871293Not ApplicableRecruiting

Evaluating the Impact of a Functional and Cognitive Strategy in Patients With Long Covid-19

NCT07518771Phase 1CompletedPrimary

PA-001 Ph.1 Study in Healthy and Elderly Subjects

NCT04418206Not ApplicableCompletedPrimary

Validating an ELISpot for Early Detection of an Active Immune Response Against COVID-19

Scroll to load more

Research Network

Activity Timeline